Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 16;13(7):654.
doi: 10.3390/antibiotics13070654.

Phyllanthus niruri Linn.: Antibacterial Activity, Phytochemistry, and Enhanced Antibiotic Combinatorial Strategies

Affiliations

Phyllanthus niruri Linn.: Antibacterial Activity, Phytochemistry, and Enhanced Antibiotic Combinatorial Strategies

Gagan Tiwana et al. Antibiotics (Basel). .

Abstract

Antimicrobial resistance (AMR) is a global public health threat caused by the misuse and overuse of antibiotics. It leads to infections becoming difficult to treat, causing serious illness, disability, and death. Current antibiotic development is slow, with only 25% of current antibiotics exhibiting novel mechanisms against critical pathogens. Traditional medicinal plants' secondary metabolites offer potential for developing novel antibacterial compounds. These compounds, often with strong antimicrobial activity, can be used to develop safe and effective antibacterial chemotherapies. This study investigated the antibacterial activity of Phyllanthus niruri Linn. extracts against a panel of bacterial pathogens using disc diffusion and microdilution assays and quantified by calculation of minimum inhibition concentration (MIC). Additionally, the effects of combinations of the extracts and selected conventional antibiotics were examined by sum of fractional inhibition concentration (ƩFIC) calculation and isobologram analysis. Liquid chromatography-mass spectrometry (LC-MS) phytochemistry analysis was used to identify noteworthy compounds in the active extracts and the Artemia nauplii bioassay was used to evaluate toxicity. The aqueous and methanolic extracts exhibited notable antibacterial activity in the broth microdilution assay against Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) (MIC = 669 µg/mL and 738 µg/mL, respectively). The methanolic extract also showed noteworthy antibacterial action in the broth assay against Klebsiella pneumoniae (MIC = 738 µg/mL). The aqueous extract had noteworthy growth inhibitory activity against Bacillus cereus (MIC = 669 µg/mL), whilst the methanolic extract demonstrated good antibacterial activity against that bacterium (MIC = 184 µg/mL). The aqueous and methanol extracts showed minimal antibacterial action against Shigella flexneri and Shigella sonnei. The extracts were subjected to LC-MS analysis, which revealed several interesting phytochemicals, including a variety of flavonoids and tannins. The antibacterial activity and lack of toxicity of the P. niruri extracts indicates that they may be worthwhile targets for antibiotic development and further mechanistic and phytochemistry studies are required.

Keywords: MRSA; antimicrobial resistance; combinational therapies; flavonoids; metabolomics; plant extracts.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Antimicrobial activity of P. niruri leaf extracts in the disc diffusion assays against (A) S. aureus, (B) MRSA, (C) E. coli, (D) ESBL E. coli, (E) K. pneumoniae, (F) ESBL K. pneumoniae. PN-AQ = P. niruri aqueous; PN-MeOH = P. niruri methanol; PN-EtOAc = P. niruri ethyl acetate. Negative controls = 1% DMSO and Blank = sterile water. Reference antibiotics: PEN G = penicillin G, ERY = erythromycin, TET = tetracycline, CHL = chloramphenicol, CIP = ciprofloxacin, POL B = polymyxin B, OXA = oxacillin, AMX = amoxycillin, GEN = gentamicin, VAN = vancomycin, AUG = Augmentin®, CEF = cefoxitin. X-axis represents samples (extracts, antibiotics, and negative controls). Horizontal red line on the y-axis at 6 mm indicates the disc diameter used in the assay. Mean values (±SEM) are reported from three independent studies. p-values < 0.01 are represented with a single asterisk symbol (*), while p-values < 0.001 are represented with a double asterisk symbol (**).
Figure 2
Figure 2
Antimicrobial activity of P. niruri leaf extracts in disc diffusion assays against (A) S. sonnei, (B) S. flexneri, (C) S. typhimurium, (D) B. cereus. PN-AQ = P. niruri aqueous; PN-MeOH = P. niruri methanol; PN-EtOAc = P. niruri ethyl acetate. Negative controls = 1% DMSO and Blank = sterile water. Reference antibiotics: PEN G = penicillin G, ERY = erythromycin, TET = tetracycline, CHL = chloramphenicol, CIP = ciprofloxacin, POL B = polymyxin B, OXA = oxacillin, AMX = amoxycillin, GEN = gentamicin, VAN = vancomycin, AUG = Augmentin®, CEF = cefoxitin. X-axis represents samples (extracts, antibiotics, and negative controls). Horizontal red line on the y-axis at 6 mm indicates the disc diameter used in the assay. Mean values (±SEM) are reported from three independent studies. p-values < 0.01 are represented with a single asterisk symbol (*), while p-values < 0.001 are represented with a double asterisk symbol (**).
Figure 3
Figure 3
Structures of noteworthy compounds identified in the P. niruri leaf extracts: (A) epicatechin; (B) fustin; (C) orientin; (D) corymboside; (E) hyperoside; (F) quercetin; (G) vitexin; (H) miquelianin; (I) myricitrin; (J) fisetin; (K) rutin; (L) trifolin; (M) kaempferol; (N) astragalin; and (O) apigenin.

References

    1. Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect. Drug Resist. 2019;12:3903–3910. doi: 10.2147/IDR.S234610. - DOI - PMC - PubMed
    1. Murray C.J.L., Ikuta K.S., Sharara F., Swetschinski L., Robles Aguilar G., Gray A., Han C., Bisignano C., Rao P., Wool E., et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0. - DOI - PMC - PubMed
    1. World Bank Group Drug-Resistant Infections: A Threat to Our Economic Future. [(accessed on 6 June 2024)]. Available online: https://www.worldbank.org/en/topic/health/publication/drug-resistant-inf....
    1. Ajulo S., Awosile B. Global Antimicrobial Resistance and Use Surveillance System (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. PLoS ONE. 2024;19:e0297921. doi: 10.1371/journal.pone.0297921. - DOI - PMC - PubMed
    1. Liu W.T., Chen E.Z., Yang L., Peng C., Wang Q., Xu Z., Chen D.Q. Emerging resistance mechanisms for 4 Types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review. Microb. Pathog. 2021;156:104915. doi: 10.1016/j.micpath.2021.104915. - DOI - PubMed

LinkOut - more resources